标普和纳斯达克内在价值 联系我们

Vivos Therapeutics, Inc. VVOS NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Devices • US • USD

SharesGrow Score
56/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.25
+66.7%

Vivos Therapeutics, Inc. (VVOS) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Devices 行业. 公司总部位于 Highlands Ranch, CO, 美国. 现任CEO为 R. Kirk Huntsman.

VVOS 拥有 IPO日期为 2020-12-11, 109 名全职员工, 在 NASDAQ Capital Marke, 市值为 $7.95M.

关于 Vivos Therapeutics, Inc.

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children. The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.

📍 9137 Ridgeline Boulevard, Highlands Ranch, CO 80129 📞 866 908 4867
公司详情
所属板块医疗保健
细分行业Medical - Devices
国家美国
交易所NASDAQ Capital Marke
货币USD
IPO日期2020-12-11
首席执行官R. Kirk Huntsman
员工数109
交易信息
当前价格$1.35
市值$7.95M
52周区间1.085-7.95
Beta6.90
ETF
ADR
CUSIP92859E108
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言